Attorneys At Law.

Archive for May, 2001

Merck Confirms Favorable Cardiovascular Safety Profile of Vioxx

May 22nd, 2001. In response to news and analyst reports of data the Company first released a year ago, Merck & Co., Inc. today reconfirmed the favorable cardiovascular safety profile of Vioxx(R) (rofecoxib), its medicine that selectively inhibits COX-2. Vioxx was approved by the Food and Drug Administration in May 1999 for the ... [More >>]

Pittsburgh, PA. Greensburg, PA. Johnstown, PA. West Virginia. Saginaw, MI Allen Park, MI.